David P. Bonita

CIK: 0001572451

Transaction Breakdown

Open Market Buys (P)5 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (10.0%)

Derivative conversions

Awards (A)3 (30.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (10.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

IMA

ImageneBio, Inc.

Director

PRLD

Prelude Therapeutics Inc

Director10% Owner

THRD

Third Harmonic Bio, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (10 total)

IMA
ImageneBio, Inc.
Jun 16, 2026
Award(A)
Stock Option (right to buy)
Direct
15.6K shares-
PRLD
Prelude Therapeutics Inc
Jun 9, 2026
Award(A)
Director Stock Option (Right to Buy)
Direct
38K shares-
PRLD
Prelude Therapeutics Inc
Apr 21, 2026
Purchase(P)
Indirect
1.7M shares at avg. $4.44$7.5M
PRLD
Prelude Therapeutics Inc
Apr 21, 2026
Purchase(P)
Indirect
1.1M shares at avg. $4.44$5.0M
IMA
ImageneBio, Inc.
Apr 14, 2026
Purchase(P)
Pre-Funded Warrants (right to buy)
Indirect
336.6K shares-
IMA
ImageneBio, Inc.
Apr 14, 2026
Purchase(P)
Pre-Funded Warrants (right to buy)
Indirect
384.7K shares-
THRD
Third Harmonic Bio, Inc.
Aug 11, 2025
Other(J)
Direct
5.8M shares-
IMA
ImageneBio, Inc.
Jul 25, 2025
Purchase(P)
Indirect
83.6K shares at avg. $29.90$2.5M
IMA
ImageneBio, Inc.
Jul 25, 2025
Exercise(M)
Direct
379 shares-
PRLD
Prelude Therapeutics Inc
Jun 12, 2025
Award(A)
Director Stock Option (Right to Buy)
Direct
38K shares-

		Type	Shares	Price		Ownership
Jun 16, 2026	IMA ImageneBio, Inc.	Award(A) Stock Option (right to buy)	15,600	-	-	Direct
Jun 9, 2026	PRLD Prelude Therapeutics Inc	Award(A) Director Stock Option (Right to Buy)	38,000	-	-	Direct
Apr 21, 2026	PRLD Prelude Therapeutics Inc	Purchase(P)	1,689,189	$4.44	$7,499,999	Indirect
Apr 21, 2026	PRLD Prelude Therapeutics Inc	Purchase(P)	1,126,126	$4.44	$4,999,999	Indirect
Apr 14, 2026	IMA ImageneBio, Inc.	Purchase(P) Pre-Funded Warrants (right to buy)	336,603	-	-	Indirect
Apr 14, 2026	IMA ImageneBio, Inc.	Purchase(P) Pre-Funded Warrants (right to buy)	384,689	-	-	Indirect
Aug 11, 2025	THRD Third Harmonic Bio, Inc.	Other(J)	5,779,071	-	-	Direct
Jul 25, 2025	IMA ImageneBio, Inc.	Purchase(P)	83,611	$29.90	$2,499,969	Indirect
Jul 25, 2025	IMA ImageneBio, Inc.	Exercise(M)	379	-	-	Direct
Jun 12, 2025	PRLD Prelude Therapeutics Inc	Award(A) Director Stock Option (Right to Buy)	38,000	-	-	Direct

1-10 of 10 transactions

About Bonita David P

Bonita David P (SEC CIK 0001572451) files insider reports with the SEC as Director of ImageneBio, Inc. (IMA), Director of Prelude Therapeutics Inc (PRLD) and Director of Third Harmonic Bio, Inc. (THRD).

Signal8 holds 7 ownership filings by Bonita David P, all Form 4s, filed between Jun 13, 2025 and Jun 18, 2026. Those filings report 10 transactions, from Jun 12, 2025 to Jun 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Bonita David P's filings is in WILMINGTON, DE.

Recent filings by Bonita David P

Jun 16, 2026: Grant or award of IMA derivative securities (Form 4, code A).
Jun 9, 2026: Grant or award of PRLD derivative securities (Form 4, code A).
Apr 21, 2026: Open-market purchases of PRLD shares (2 lines, Form 4, code P).
Apr 14, 2026: Open-market purchases of IMA derivative securities (2 lines, Form 4, code P).
Aug 11, 2025: Other transaction of THRD shares (Form 4, code J).

Other insiders filing for ImageneBio, Inc. (IMA)

Yarema Kristin, Chief Executive Officer
Grant-Huerta Yanina, Chief Financial Officer
Lally Robert B, Principal Accounting Officer
Wang Jonathan Jian, Director
Stampacchia Otello, Director
SLATTERY JOSEPH P, Director

How to read Form 4 transaction codes